Trial · NCT07896057
Evidence-based, Customized, Motion-recognition Rehabilitation System Development for Bed-ridden Patients - Validation of Effectiveness: Rehabit: Swim
NCT07896057, Not applicable, Not yet recruiting, Asan Medical Center
3 sourcestrials-2026-11-12-0.5.0
Cite this record
ConductScience Library. Evidence-based, Customized, Motion-recognition Rehabilitation System Development for Bed-ridden Patients - Validation of Effectiveness: Rehabit: Swim. Trials, record NCT07896057. Release trials-2026-11-12-0.5.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT07896057
On this page
Trial
As registered on ClinicalTrials.gov, in the graph's capture of the registry.
- Title
- Evidence-based, Customized, Motion-recognition Rehabilitation System Development for Bed-ridden Patients - Validation of Effectiveness: Rehabit: Swim
- NCT number
- NCT07896057
- Status
- Not yet recruiting
- Phases
- Not applicable
- Enrollment
- 20 participants, estimated
- Lead sponsor
- Asan Medical Center
- Conditions
- ICU-acquired Weakness
- Interventions
- Rehabilitation
- First posted
- 2026-10-26
- Last updated
- 2026-10-26
Source ClinicalTrials.gov
Registered outcomes10
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Session Adherence Rate | From the first intervention session (Game 1) through the tenth session (Game 10), up to 3 weeks | Percentage of the 10 planned Rehabit: swim sessions attended by each participant, calculated as (number of sessions attended ÷ 10) × 100. A session is counted as attended when the participant starts the scheduled exercise-game session. |
| Primary | Intervention Completion Rate | From the first intervention session (Game 1) through the tenth session (Game 10), up to 3 weeks | Percentage of enrolled participants who complete all 10 Rehabit: swim sessions within 3 weeks of the first session. |
| Secondary | Medical Research Council Sum Score (MRC-SS) | Baseline and post-intervention (approx. 2 weeks). | Change in muscle strength assessed using the MRC-SS. Scores range from 0 to 60; higher scores indicate greater muscle strength (better outcome). |
| Secondary | Grip Strength | Baseline and post-intervention (approx. 2 weeks). | Change in handgrip strength. |
| Secondary | Functional Ambulatory Category (FAC) | Baseline and post-intervention (approx. 2 weeks). | Changes in functional mobility and ambulation status measured by the Functional Ambulation Category (FAC). Scores range from 0 (nonfunctional ambulator) to 5 (independent ambulator on any surface, including stairs); higher scores indicate greater walking independence (better outcome). |
| Secondary | ICU Mobility Scale (ICU-MS) | Baseline and post-intervention (approx. 2 weeks). | Changes in functional mobility and ambulation status measured by the Intensive Care Unit Mobility Scale (ICU-MS). Scores range from 0 (lying in bed, no active movement) to 10 (walking independently without a gait aid); higher scores indicate greater mobility (better outcome). |
| Secondary | EQ-5D-5L Index | Baseline and post-intervention (approx. 2 weeks). | Health-related quality of life measured with the EuroQol 5-Dimension 5-Level questionnaire (EQ-5D-5L), which assesses mobility, self-care, usual activities, pain/discomfort, and anxiety/depression, each rated on 5 levels from no problems to extreme problems. Responses are converted to a single index value using the Korean EQ-5D-5L value set (range -0.066 to 1; higher values indicate better health). Change is calculated as the post-intervention value minus the baseline value; positive values indicate improvement. |
| Secondary | EQ-VAS | Baseline and post-intervention (approx. 2 weeks). | Self-rated overall health measured with the EQ-VAS, ranging from 0 (worst imaginable health) to 100 (best imaginable health); higher scores indicate better self-rated health. Change is calculated as the post-intervention score minus the baseline score; positive values indicate improvement. |
| Secondary | Intrinsic Motivation Inventory (IMI) Interest/Enjoyment Subscale Score | Baseline and post-intervention (approx. 2 weeks). | Intrinsic motivation toward the Rehabit: swim exercise game measured with the Interest/Enjoyment subscale of the IMI, consisting of 7 items rated from 1 ("not at all true") to 7 ("very true"), with 2 items reverse-scored. The subscale score is the mean of the 7 items (range 1 to 7); higher scores indicate greater intrinsic motivation. |
| Secondary | Game User Experience Satisfaction Scale-18 (GUESS-18) Composite Score | Baseline and post-intervention (approx. 2 weeks). | Satisfaction with the Rehabit: swim exercise game measured with the GUESS-18, consisting of 18 items across 9 subscales rated from 1 ("strongly disagree") to 7 ("strongly agree"), with 1 item reverse-scored. Items are averaged within each subscale, and the 9 subscale scores are summed to obtain the composite score (range 9 to 63); higher scores indicate greater game satisfaction. |
Source ClinicalTrials.gov
Outcomes0
Each outcome the trial posted results for, in ClinicalTrials.gov's words.
None in this release.
Results by group0
Each measurement the trial posted, group by group, in the words and numbers it posted.
None in this release.
Participant flow0
How many started, completed or left each group, period by period.
None in this release.
Adverse events0
Each adverse event the trial posted, group by group: the participants affected out of those at risk.
None in this release.
Adverse event totals0
The totals the trial posted for each group.
None in this release.
Papers0
The papers the trial lists on ClinicalTrials.gov.
None in this release.
Grants0
The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.
None in this release.
Trial comparisons0
Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.
None in this release.
Tests0
The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.
None in this release.
Data dates
The day each source was copied for this release.
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this trial from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/trials/v1/NCT07896057
GET https://conductscience.org/api/trials/v1/NCT07896057/registered